Search

everythinglearnresearchcommunity

for

Search:↓

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Finasteride helps female-pattern hair loss.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Blocking mTORC1 reduces skin tumor growth in mice.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

AQB reduces harmful skin changes in systemic sclerosis.

New cytokine-targeted therapies show promise for treating alopecia areata.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Blocking interferon-gamma might help treat various autoimmune diseases.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Tofacitinib helped a woman regrow hair with no major side effects.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.